Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A10AE04	TOUJEO	BioTech	Insulin glargine - 300Units/ml	300Units/ml	Injectable solution	4,559,658 L.L
A10AE06	TRESIBA	BioTech	Insulin degludec - 100IU/ml	100IU/ml	Injectable solution	6,857,628 L.L
A11DB	TRILAGAVIT	G	Vitamin B12 - 1mg/3ml, Vitamin B6 - 100mg/3ml, Vitamin B1 - 100mg/3ml		Injectable solution	579,196 L.L
L01FF05	TECENTRIQ	BioTech	Atezolizumab - 1875mg/15ml	1875mg/15ml	Injectable solution	375,054,619 L.L
L04AC13	TALTZ	BioTech	Ixekizumab - 80mg/ml	80mg/ml	Injectable solution	85,080,792 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	190,195,151 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	190,195,151 L.L
G02CX01	TRACTOCILE	B	Atosiban acetate - 7.5mg/ml	7.5mg/ml	Injectable solution	2,592,272 L.L
G02CX01	TRACTOCILE	B	Atosiban acetate - 7.5mg/ml	7.5mg/ml	Injectable solution	8,282,804 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	L.L
B06AC05	TAKHZYRO	BioTech	Lanadelumab - 300mg/2ml		Injectable solution	1,204,227,927 L.L
G03BA03	TESTOVIRON DEPOT	B	Testosterone Enantate - 250mg/ml	250mg/ml	Injectable solution	467,657 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 10mg/ml	10mg/ml	Injectable solution	95,166,436 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 90mg/ml	90mg/ml	Injectable solution	483,720,518 L.L
L01FX29	TALVEY	B	Talquetamab - 2mg/ml	3mg/1.5ml	Injectable solution	45,594,403 L.L
L01FX29	TALVEY	B	Talquetamab - 40mg/ml	40mg/ml	Injectable solution	555,916,745 L.L
A04AA01	TRONDAMET	G	Ondansetron (HCl) - 4mg/2ml	4mg/2ml	Injectable solution	2,027,858 L.L
A04AA01	TRONDAMET	G	Ondansetron (HCl) - 8mg/4ml	8mg/4ml	Injectable solution	2,027,858 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 90mg/ml	90mg/ml	Injectable solution	L.L
M01AB05	TRATUL	G	Diclofenac Deanol - 90mg	90mg	Injectable solution	490,503 L.L
J07AP03	TYPHIBEV TYPHOID CONJUGATED VACCINE (MONOVALENT)	B	Salmonella typhi polysaccharides Vi purified - 25mcg of Vi-PS2/0.5ml		Injectable suspension	4,020,777 L.L
J07CA02	TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactivé adsorbé)	B	Diphteria toxoid purified - ?30IU, Tetanus toxoid purified - ?40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg		Injectable suspension	1,628,737 L.L
H02AB08	TRIACORT	G	Triamcinolone acetonide - 40mg/ml	40mg/ml	Injectable suspension	745,833 L.L
N05AX13	TREVICTA	B	Paliperidone - 175mg	175mg	Injectable suspension, prolonged release	35,006,953 L.L
N05AX13	TREVICTA	B	Paliperidone - 263mg	263mg	Injectable suspension, prolonged release	40,713,332 L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	50,113,800 L.L
N05AX13	TREVICTA	B	Paliperidone - 525mg	525mg	Injectable suspension, prolonged release	75,169,378 L.L
R02A	TRACHISAN	G	Lidocaine HCl - 1mg, Tyrothricin - 0.5mg, Chlorhexidine gluconate - 1mg		Lozenge	228,453 L.L
D11AH01	TACRUS	G	Tacrolimus monohydrate - 0.1%	0.10%	Ointment	1,857,190 L.L
S01AA09	TETRACYCLINE EYE OINTMENT	G	Tetracycline HCl - 1%	1%	Ointment	71,672 L.L

...